US Stock MarketDetailed Quotes
NVNO enVVeno Medical
- 2.820
- -0.090-3.09%
Close Dec 24 13:00 ET
- 2.820
- 0.0000.00%
Post 17:01 ET
49.45MMarket Cap-2.19P/E (TTM)
2.950High2.790Low109.72KVolume2.910Open2.910Pre Close313.67KTurnover0.64%Turnover RatioLossP/E (Static)17.54MShares6.97052wk High1.04P/B48.71MFloat Cap2.45052wk Low--Dividend TTM17.27MShs Float141.000Historical High--Div YieldTTM5.50%Amplitude2.450Historical Low2.858Avg Price1Lot Size
About enVVeno Medical Company
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Company Profile
SymbolNVNO
Company NameenVVeno Medical
Listing DateMay 31, 2018
Founded1999
CEOMr. Robert A. Berman
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address70 Doppler
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-261-2900
Websitehttp://www.envveno.com
Company Executives
- Name
- Position
- Salary
- Robert A. Berman
- Director and Chief Executive Officer
- 1.87M
- Dr. Marc H. Glickman, M.D.
- Senior Vice President and Chief Medical Officer
- 776.38K
- Craig Glynn
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 527.29K
- Robert C. Gray
- Independent Director
- 77.50K
- Dr. Francis Duhay
- Independent Director
- 70.00K
- Dr. Sanjay Shrivastava
- Independent Director
- 75.00K
- Matthew M. Jenusaitis
- Independent Director
- 75.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
